Net profit of Epigral rose 114.00% to Rs 81.30 crore in the quarter ended September 2024 as against Rs 37.99 crore during the previous quarter ended September 2023. Sales rose 30.93% to Rs 626.06 crore in the quarter ended September 2024 as against Rs 478.15 crore during the previous quarter ended September 2023.
Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
Sales | 626.06 | 478.15 | 31 |
OPM % | 28.50 | 22.53 | - |
PBDT | 157.43 | 87.45 | 80 |
PBT | 125.18 | 55.94 | 124 |
NP | 81.30 | 37.99 | 114 |